CVRx, Inc. Release: Four-Year Clinical Study Findings Show Significant and Persistent Reduction in Blood Pressure with Rheos(R) System

Published: Jun 21, 2010

MINNEAPOLIS & OLSO, Norway--(BUSINESS WIRE)--CVRx, Inc. announced today the four-year Rheos clinical results from the European study evaluating the RheosĀ® System at the European Society of Hypertension 20th Meeting. The system is the first device designed to treat hypertension (high blood pressure), a leading cause of heart and kidney disease, stroke and death. This device is a future treatment option for the millions of people who cannot control their blood pressure with medications.

Back to news